Roche to Acquire Poseida Therapeutics in Strategic Merge
Roche has formally declared its intent to purchase Poseida Therapeutics, Inc., a publicly traded clinical-stage biopharmaceutical firm that specializes in developing donor-derived CAR-T cell therapies. Situated in San Diego, California, Poseida has a robust research and development portfolio with both […]
Roche to Acquire Poseida Therapeutics in Strategic Merge Read More »